Phase II study of VP16-213 (Etoposide) in refractory metastatic breast carcinoma

1982 ◽  
Vol 7 (2-3) ◽  
Author(s):  
F.C. Schell ◽  
H.Y. Yap ◽  
G.N. Hortobagyi ◽  
B. Issell ◽  
L. Esparza
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Metastatic Breast Carcinoma

scholarly journals M-VAC combination in locally advanced, locally recurrent or metastatic breast carcinoma. A phase II study

1994 ◽  
Vol 5 (1) ◽  
pp. 93-94 ◽  
Author(s):  
G. Bisagni ◽  
G. Cocconi ◽  
B. Di Blasio ◽  
G. Ceci ◽  
V. De Lisi ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Locally Advanced ◽  
Metastatic Breast ◽  
Metastatic Breast Carcinoma ◽  
Locally Recurrent

Phase II Study with Pirarubicin in Metastatic Breast Carcinoma

1989 ◽  
pp. 94-102
Author(s):  
U. R. Kleeberg ◽  
L. Reichel ◽  
J. Rau ◽  
H. E. Wander ◽  
U. Essers ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Metastatic Breast Carcinoma

scholarly journals A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma

Cancer ◽  
2000 ◽  
Vol 88 (1) ◽  
pp. 124-131 ◽  
Author(s):  
Edith A. Perez ◽  
David W. Hillman ◽  
Philip J. Stella ◽  
James E. Krook ◽  
Lynn C. Hartmann ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
First Line ◽  
Metastatic Breast Carcinoma ◽  
Line Chemotherapy

scholarly journals Weekly pegylated liposomal doxorubicin and paclitaxel in patients with metastatic breast carcinoma: A phase II study

2010 ◽  
Vol 1 (4) ◽  
pp. 749-753 ◽  
Author(s):  
VITA LEONARDI ◽  
VALENTINA PALMISANO ◽  
ALESSIO PEPE ◽  
ANTONELLA USSET ◽  
GIOVANNA MANUGUERRA ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Pegylated Liposomal Doxorubicin ◽  
Metastatic Breast Carcinoma

scholarly journals A Phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with metastatic breast carcinoma

Cancer ◽  
2003 ◽  
Vol 98 (5) ◽  
pp. 900-907 ◽  
Author(s):  
Francisco J. Esteva ◽  
Edgardo Rivera ◽  
Massimo Cristofanilli ◽  
Vicente Valero ◽  
Melanie Royce ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Metastatic Breast Carcinoma ◽  
Exatecan Mesylate

scholarly journals A Phase II study of paclitaxel by 24-hour infusion and ifosfamide in anthracycline-resistant metastatic breast carcinoma

Cancer ◽  
2002 ◽  
Vol 94 (7) ◽  
pp. 1925-1930 ◽  
Author(s):  
Jae H. Seo ◽  
Young M. Whang ◽  
Byung S. Kim ◽  
Chul W. Choi ◽  
Sang W. Shin ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Metastatic Breast Carcinoma
Sign in / Sign up

Export Citation Format

Share Document